Medical Advocates
Ethics and Infectious Diseases
  Ethical Challenges
Screening/Testing
 Refusal of Care/Services
Detention
Patient Exploitation
Compulsory Treatment
Decision-Making
Reproduction
Transplants
End-of-Life Care
Enteral Nutrition
Professional Associations
National Challenges         Sterilization
Bioterrorism                     Prison Challenges
 HIV Exceptionalism           Conflicts of Interest
Pharmaceutical Industry   Pregnancy
HIV Prevention   
Stigma
 Physician Reimbursement 
Ethics and Disease Challenges and Duties
 HIV Cure
 Ebola Virus Disease
 Executions






 
Ethics Main Page Main New and Noteworthy Home Page

Medical Advocates
Abacavir (Ziagen)
 
Pediatric Index

US Treatment Guidelines
Pharmacokinetics
 Viral Dynamics
 Efficacy
Adherence
 Salvage Therapy
 Drug Alerts


 

 
Abacavir Main Page Main New/Newsworthy    Home Page    
Last Update:  January 26, 2015
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Pharmacokinetics
 

    Journal Papers, Abstracts, and Commentaries

 
Population pharmacokinetics of abacavir in infants, toddlers and children.
Zhao W, Piana C, Danhof M,  et al
Br J Clin Pharmacol. 2012 Nov 5.
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir:
application of individualized therapy in HIV infected infants and toddlers.
Zhao W, Cella M, Della Pasqua O, et al
Br J Clin Pharmacol. 2011 Oct 11.
 Abstract

Abacavir and Metabolite Pharmacokinetics in HIV-1-Infected Children and Adolescents.
 Cross SJ, Rodman JH, Lindsey JC, et al
J Acquir Immune Defic Syndr. 2009 Mar 11
 Abstract

Abacavir pharmacokinetics in human immunodeficiency virus-infected children ranging in age
from 1 month to 16 years: a population analysis.
 Jullien V, Urien S, Chappuy H, et al  
J Clin Pharmacol. 2005 Mar;45(3):257-64.
Abstract
Viral Dynamics
 

    Journal Papers, Abstracts, and Commentaries
 
  Virologic Response in Children Treated with Abacavir Compared with Stavudine-Based Antiretroviral Treatment – A South African Multi-Cohort Analysis.
Technau KG, Schomaker M, Kuhn L, et al 
Pediatr Infect Dis J. 2013 Dec 30.
 Abstract
Efficacy Data
 

    Journal Papers, Abstracts, and Commentaries

  FULL-TEXT PDF ARTICLE
 Antiviral efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV-infected children and adolescents: a systematic review protocol.
 Adetokunboh OO, Schoonees A, Wiysonge CS.
Syst Rev. 2014 Aug 12;3(1):87.
 Paper

Poor Early Virologic Performance and Durability of Abacavir-based First-line Regimens for HIV-infected Children.
Technau KG, Lazarus E, Kuhn L, et al 
Pediatr Infect Dis J. 2013 Aug;32(8):851-855
 Abstract

A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral
agents in infants and children with human immunodeficiency virus infection. AIDS Clinical
Trials Group 330 Team.
Kline MW, Blanchard S, Fletcher CV et al.
Pediatrics 1999; 103(4): e47.
Abstract

     Conference Reports, Abstracts and Posters

 

24-month treatment outcomes amongst HIV-positive children and adolescent patients prescribed stavudine vs. abacavir
A.T. Brennan, M. Maskew, L. Long
(XX International AIDS Conference)
 Abstract
Highly active antiretroviral therapy including high dose abacavir reduces cerebrospinal fluid human
immunodeficiency virus (HIV) RNA and soluble tumor necrosis factor II receptor in children with HIV
encephalopathy
Saavedra-Lozano, S Madison, et al
(14IAC)
 Abstract

Antiretroviral efficacy and tolerability of Abacavir (ABC) based regimens in a clinical cohort
of HIV-infected children
F Hoffmann, T Niehues, B Buchholz, et al
 (14IAC)
Abstract
Adherence
 

     Conference Reports, Abstracts and Posters

  Adherence and acceptability of once daily lamivudine and abacavir in HIV-1
infected children.
LeProvost M., Flynn J., Green H., Gibb D.M., et al
 (3rd IAS)
 Abstract
Adverse Events
 

     Conference Reports, Abstracts and Posters

  POSTER
 Successful management of suspected abacavir hypersensitivity reactions among
African children in the ARROW (AntiRetroviral Research fOr Watoto) trial
P. Nahirya-Ntege, B. Naidoo, K.J. Nathoo
 (15 IAS)
PDF Poster     Abstract
 
Salvage Therapy
 

    Journal Papers, Abstracts, and Commentaries
 
  Salvage Therapy With Abacavir and Other Reverse Transcriptase Inhibitors for Human
Immunodeficiency-Associated Encephalopathy.
 Saavedra-Lozano J, Ramos JT, Navarro ML, et al 
Pediatr Infect Dis J. 2006 Dec;25(12):1142-1152.
Abstract
 
Drug Alerts
         
Abacavir